Dr. Leung’s research focuses on the development of advanced drug delivery systems for novel biological antibacterials, including phage and phage-encoded proteins, to combat difficult-to-treat bacterial infections.

Courtney Luo is a PhD candidate at the Sydney Pharmacy School, The University of Sydney. She completed her Bachelor of Pharmacy at the same institution and has since gained research experience in pharmaceutical sciences. Her doctoral research focuses on the interaction between polymyxin antibiotics and the human oligopeptide transporter 2 (hPepT2), aiming to develop safer and more effective treatments for multidrug-resistant Gram-negative bacterial infections. She has experience in molecular biology techniques including mutagenesis, transfection, and protein expression analysis. Courtney is also actively involved in HDR student representation and academic engagement activities. Her broader research interests include antibiotic resistance, transporter pharmacology, and rational drug design.

Elissar is an early career clinical pharmacist in NSW and is currently in the second year of her PhD at the University of Sydney under the supervision of Professor Paul Groundwater. After completing her honours project in 2022 in the field of AMR, she grew a passion for drug discovery and decided to pursue post-graduate studies in drug development of new antibacterial agents with the same research team who helped her get a kick start in research.

Eleni is a registered and practising pharmacist, and casual academic at the University of Sydney, having graduated from Sydney Pharmacy School's Bachelor of Pharmacy (Hons I) program in 2021. Currently, Eleni is a PhD candidate at Sydney Pharmacy School and the Centre for Infectious Diseases at the Westmead Institute for Medical Research. Her project is multidisciplinary and spans across developing shelf-stable therapeutic phage formulations and phage-drug conjugates for the site-specific delivery of therapeutic payloads to combat antibiotic resistance.

Dr Suhaili Shamsi has served as a senior lecturer in the Department of Biochemistry, Faculty of Biochemistry and Biomolecular Sciences, Universiti Putra Malaysia, after completing her PhD in Pharmacy from the University of Western Australia in 2015. Currently, her research is based in the Laboratory of Animal Biochemistry and Biotechnology, which focuses on research related to drug delivery, nanotechnology, pharmaceutical sciences, drug metabolism and toxicology. Dr Suhaili Shamsi has received more than RM500,000 research grant, as both principal investigator and research collaborator. Dr Suhaili is also actively publishing research articles in highly reputable journals.

Prof. Richard Ye received his PhD from Washington University in St. Louis and is currently Presidential Chair Professor and Associate Dean of School of Medicine, The Chinese University of Hong Kong, Shenzhen. Prof. Ye and his research team focus on the development of anti-infectious and anti-inflammatory therapies. He has published more than 240 research papers and is a highly cited scholar. Among his major discovery and characterization of the chemoattractant receptor FPR2, and the identification of SAA for its LPS binding properties. These studies have led to the development of biased agonists for anti-inflammatory therapy through FPR2, and peptides for LPS clearance as a potential therapy for sepsis caused by infection of Gram-negative bacteria.

Elin Julianti, is associate professor at the Department of Pharmacochemistry, School of Pharmacy, ITB. Her research interest and courses focus on pharmaceutical microbiology as well as the exploration of biologically active metabolites from marine-derived microorganisms, especially metabolites with antimicrobial and cytotoxic activity. She has extensive experience in separation and isolation of natural products and in vitro experiment of antimicrobial and cytotoxic activity assay. Investigation of structurally novel and biologically active compounds from marine-derived microorganisms has become an important research area in drug discovery. Her contribution to this research area is published around 40 research articles (h-index 11)